Radiopharmaceutical Theranostics Market, Global Outlook and Forecast 2022-2028
Report Code: KNJ1325838 No. of Pages: 68 Category: Consumer Goods and Retail
Publisher: Date of Publish:
Publisher: Date of Publish:
Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease.
This report contains market size and forecasts of Radiopharmaceutical Theranostics in Global, including the following market information:
Global Radiopharmaceutical Theranostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Radiopharmaceutical Theranostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oncology Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Radiopharmaceutical Theranostics include Nihon Medi-Physics, ITM Isotopen Technologien München AG, Advanced Accelerator Applications, Telix Pharmaceuticals, GE Healthcare, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited and Lantheus Holdings, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Radiopharmaceutical Theranostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Radiopharmaceutical Theranostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Radiopharmaceutical Theranostics Market Segment Percentages, by Type, 2021 (%)
Oncology
Cardiology
Others
Global Radiopharmaceutical Theranostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Radiopharmaceutical Theranostics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Academic & Research Institutes
Others
Global Radiopharmaceutical Theranostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Radiopharmaceutical Theranostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Radiopharmaceutical Theranostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Radiopharmaceutical Theranostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nihon Medi-Physics
ITM Isotopen Technologien München AG
Advanced Accelerator Applications
Telix Pharmaceuticals
GE Healthcare
Theragnostics Ltd.
NuView Life Sciences
Jubilant Pharma Limited
Lantheus Holdings, Inc.
Curium Pharma
Bayer AG
Clarity Pharmaceuticals
1 Introduction to Research & Analysis Reports
1.1 Radiopharmaceutical Theranostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radiopharmaceutical Theranostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Radiopharmaceutical Theranostics Overall Market Size
2.1 Global Radiopharmaceutical Theranostics Market Size: 2021 VS 2028
2.2 Global Radiopharmaceutical Theranostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Radiopharmaceutical Theranostics Players in Global Market
3.2 Top Global Radiopharmaceutical Theranostics Companies Ranked by Revenue
3.3 Global Radiopharmaceutical Theranostics Revenue by Companies
3.4 Top 3 and Top 5 Radiopharmaceutical Theranostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Radiopharmaceutical Theranostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Radiopharmaceutical Theranostics Players in Global Market
3.6.1 List of Global Tier 1 Radiopharmaceutical Theranostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Radiopharmaceutical Theranostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Radiopharmaceutical Theranostics Market Size Markets, 2021 & 2028
4.1.2 Oncology
4.1.3 Cardiology
4.1.4 Others
4.2 By Type - Global Radiopharmaceutical Theranostics Revenue & Forecasts
4.2.1 By Type - Global Radiopharmaceutical Theranostics Revenue, 2017-2022
4.2.2 By Type - Global Radiopharmaceutical Theranostics Revenue, 2023-2028
4.2.3 By Type - Global Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Radiopharmaceutical Theranostics Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Academic & Research Institutes
5.1.4 Others
5.2 By Application - Global Radiopharmaceutical Theranostics Revenue & Forecasts
5.2.1 By Application - Global Radiopharmaceutical Theranostics Revenue, 2017-2022
5.2.2 By Application - Global Radiopharmaceutical Theranostics Revenue, 2023-2028
5.2.3 By Application - Global Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Radiopharmaceutical Theranostics Market Size, 2021 & 2028
6.2 By Region - Global Radiopharmaceutical Theranostics Revenue & Forecasts
6.2.1 By Region - Global Radiopharmaceutical Theranostics Revenue, 2017-2022
6.2.2 By Region - Global Radiopharmaceutical Theranostics Revenue, 2023-2028
6.2.3 By Region - Global Radiopharmaceutical Theranostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Radiopharmaceutical Theranostics Revenue, 2017-2028
6.3.2 US Radiopharmaceutical Theranostics Market Size, 2017-2028
6.3.3 Canada Radiopharmaceutical Theranostics Market Size, 2017-2028
6.3.4 Mexico Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Radiopharmaceutical Theranostics Revenue, 2017-2028
6.4.2 Germany Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4.3 France Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4.4 U.K. Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4.5 Italy Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4.6 Russia Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4.7 Nordic Countries Radiopharmaceutical Theranostics Market Size, 2017-2028
6.4.8 Benelux Radiopharmaceutical Theranostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Radiopharmaceutical Theranostics Revenue, 2017-2028
6.5.2 China Radiopharmaceutical Theranostics Market Size, 2017-2028
6.5.3 Japan Radiopharmaceutical Theranostics Market Size, 2017-2028
6.5.4 South Korea Radiopharmaceutical Theranostics Market Size, 2017-2028
6.5.5 Southeast Asia Radiopharmaceutical Theranostics Market Size, 2017-2028
6.5.6 India Radiopharmaceutical Theranostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Radiopharmaceutical Theranostics Revenue, 2017-2028
6.6.2 Brazil Radiopharmaceutical Theranostics Market Size, 2017-2028
6.6.3 Argentina Radiopharmaceutical Theranostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Radiopharmaceutical Theranostics Revenue, 2017-2028
6.7.2 Turkey Radiopharmaceutical Theranostics Market Size, 2017-2028
6.7.3 Israel Radiopharmaceutical Theranostics Market Size, 2017-2028
6.7.4 Saudi Arabia Radiopharmaceutical Theranostics Market Size, 2017-2028
6.7.5 UAE Radiopharmaceutical Theranostics Market Size, 2017-2028
7 Players Profiles
7.1 Nihon Medi-Physics
7.1.1 Nihon Medi-Physics Corporate Summary
7.1.2 Nihon Medi-Physics Business Overview
7.1.3 Nihon Medi-Physics Radiopharmaceutical Theranostics Major Product Offerings
7.1.4 Nihon Medi-Physics Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.1.5 Nihon Medi-Physics Key News
7.2 ITM Isotopen Technologien München AG
7.2.1 ITM Isotopen Technologien München AG Corporate Summary
7.2.2 ITM Isotopen Technologien München AG Business Overview
7.2.3 ITM Isotopen Technologien München AG Radiopharmaceutical Theranostics Major Product Offerings
7.2.4 ITM Isotopen Technologien München AG Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.2.5 ITM Isotopen Technologien München AG Key News
7.3 Advanced Accelerator Applications
7.3.1 Advanced Accelerator Applications Corporate Summary
7.3.2 Advanced Accelerator Applications Business Overview
7.3.3 Advanced Accelerator Applications Radiopharmaceutical Theranostics Major Product Offerings
7.3.4 Advanced Accelerator Applications Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.3.5 Advanced Accelerator Applications Key News
7.4 Telix Pharmaceuticals
7.4.1 Telix Pharmaceuticals Corporate Summary
7.4.2 Telix Pharmaceuticals Business Overview
7.4.3 Telix Pharmaceuticals Radiopharmaceutical Theranostics Major Product Offerings
7.4.4 Telix Pharmaceuticals Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.4.5 Telix Pharmaceuticals Key News
7.5 GE Healthcare
7.5.1 GE Healthcare Corporate Summary
7.5.2 GE Healthcare Business Overview
7.5.3 GE Healthcare Radiopharmaceutical Theranostics Major Product Offerings
7.5.4 GE Healthcare Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.5.5 GE Healthcare Key News
7.6 Theragnostics Ltd.
7.6.1 Theragnostics Ltd. Corporate Summary
7.6.2 Theragnostics Ltd. Business Overview
7.6.3 Theragnostics Ltd. Radiopharmaceutical Theranostics Major Product Offerings
7.6.4 Theragnostics Ltd. Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.6.5 Theragnostics Ltd. Key News
7.7 NuView Life Sciences
7.7.1 NuView Life Sciences Corporate Summary
7.7.2 NuView Life Sciences Business Overview
7.7.3 NuView Life Sciences Radiopharmaceutical Theranostics Major Product Offerings
7.7.4 NuView Life Sciences Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.7.5 NuView Life Sciences Key News
7.8 Jubilant Pharma Limited
7.8.1 Jubilant Pharma Limited Corporate Summary
7.8.2 Jubilant Pharma Limited Business Overview
7.8.3 Jubilant Pharma Limited Radiopharmaceutical Theranostics Major Product Offerings
7.8.4 Jubilant Pharma Limited Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.8.5 Jubilant Pharma Limited Key News
7.9 Lantheus Holdings, Inc.
7.9.1 Lantheus Holdings, Inc. Corporate Summary
7.9.2 Lantheus Holdings, Inc. Business Overview
7.9.3 Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Major Product Offerings
7.9.4 Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.9.5 Lantheus Holdings, Inc. Key News
7.10 Curium Pharma
7.10.1 Curium Pharma Corporate Summary
7.10.2 Curium Pharma Business Overview
7.10.3 Curium Pharma Radiopharmaceutical Theranostics Major Product Offerings
7.10.4 Curium Pharma Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.10.5 Curium Pharma Key News
7.11 Bayer AG
7.11.1 Bayer AG Corporate Summary
7.11.2 Bayer AG Business Overview
7.11.3 Bayer AG Radiopharmaceutical Theranostics Major Product Offerings
7.11.4 Bayer AG Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.11.5 Bayer AG Key News
7.12 Clarity Pharmaceuticals
7.12.1 Clarity Pharmaceuticals Corporate Summary
7.12.2 Clarity Pharmaceuticals Business Overview
7.12.3 Clarity Pharmaceuticals Radiopharmaceutical Theranostics Major Product Offerings
7.12.4 Clarity Pharmaceuticals Radiopharmaceutical Theranostics Revenue in Global Market (2017-2022)
7.12.5 Clarity Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com